The role of HPSE in BRAF V600E-mutant colorectal cancer.

3530Background: BRAF mutations occur in about 10% of colorectal cancer (CRC), more than 90% of which are BRAF V600E mutation. Patients (pts) with BRAF V600E mutation present poor prognosis. Complex...